Department of Neurosurgery and Neurooncology, Medical University of Lodz, Barlicki University Hospital, Kopcińskiego 22, 90-153 Lodz, Poland.
Department of Biostatistics and Translational Medicine, Medical University of Lodz, 36/50 Sporna, 91-738 Lodz, Poland.
J Clin Neurosci. 2019 Oct;68:151-157. doi: 10.1016/j.jocn.2019.07.007. Epub 2019 Jul 12.
Carotid-ophthalmic aneurysms are indication for endovascular treatment. Coil embolization is associated with a high recanalization rate and thus usage of flow diverter (FD) could constitute the treatment of choice. Although implementation of FD is very effective, it carries a significant risk of complications. The goal of our study was to find a radiological recanalization marker in order to facilitate decision process which would result in fewer treatment-related complications and in this way, to personalize endovascular therapy. We made a retrospective analysis of seventy-five patients with saccular carotid-ophthalmic aneurysms treated endovascularly. Morphometric measurements were performed in CTA 3D aneurysm models. The aneurysm size and volume were measured on the base of digital subtraction angiography (DSA) images. The treatment effectiveness was determined visually using the modified Raymond Roy classification after embolization and on the 6- and 12-month follow-up DSA. Statistica 13.1 software was used. Multivariate analyses showed that the aneurysm neck size (OR 2.51; 95%CI: 1.20-5.26), aspect ratio (OR 2.60; 95%CI: 1.27-5.21) and neck to parent artery ratio (OR 2.68; 95%CI: 1.26-5.70) were risk factors for carotid-ophthalmic aneurysms recanalization after 6 months. Of those factors, aneurysm neck size remained the only significant risk factor for carotid-ophthalmic aneurysms recanalization after 12 months (OR 5.23, 95%CI: 1.71-15.93). Various factors seem to influence recanalization. Preoperatively, if the above-mentioned predictors of recanalization are present, coiling is burdened with a high recanalization rate. In those cases, FD embolization should be considered.
颈内动脉-眼动脉动脉瘤是血管内治疗的指征。线圈栓塞与高再通率相关,因此使用血流导向装置(FD)可能构成首选治疗方法。虽然 FD 的实施非常有效,但它存在着显著的并发症风险。我们研究的目的是寻找一种影像学再通标志物,以便为决策过程提供便利,从而减少与治疗相关的并发症,并以此实现血管内治疗的个体化。我们对 75 例接受血管内治疗的囊状颈内动脉-眼动脉动脉瘤患者进行了回顾性分析。在 CTA 3D 动脉瘤模型中进行形态测量。根据数字减影血管造影(DSA)图像测量动脉瘤的大小和体积。栓塞后及 6 个月和 12 个月的 DSA 随访时,使用改良 Raymond Roy 分类进行视觉评估治疗效果。使用 Statistica 13.1 软件进行多变量分析。多变量分析显示,动脉瘤颈部大小(OR 2.51;95%CI:1.20-5.26)、形态比(OR 2.60;95%CI:1.27-5.21)和颈部与母动脉比值(OR 2.68;95%CI:1.26-5.70)是 6 个月后颈内动脉-眼动脉动脉瘤再通的危险因素。在这些因素中,动脉瘤颈部大小仍然是 12 个月后颈内动脉-眼动脉动脉瘤再通的唯一显著危险因素(OR 5.23,95%CI:1.71-15.93)。各种因素似乎都影响再通。术前,如果存在上述再通预测因素,线圈栓塞的再通率较高。在这些情况下,应考虑使用 FD 栓塞。